Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Ataga KI, et al. Among authors: liles d. N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3. N Engl J Med. 2017. PMID: 27959701 Free PMC article. Clinical Trial.
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, Achebe MM, Boccia R, Crary SE, Kraft WK, Archer N, Cataldo V, Hardesty BM, Idowu M, Desai PC, Ikeda A, Puthenveetil G, Hassell KL, Sarnaik S, Kutlar A. Liles DK, et al. Br J Haematol. 2021 Nov;195(4):e150-e153. doi: 10.1111/bjh.17739. Epub 2021 Oct 5. Br J Haematol. 2021. PMID: 34611900 No abstract available.
Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.
Badawy SM, Abebe KZ, Reichman CA, Checo G, Hamm ME, Stinson J, Lalloo C, Carroll P, Saraf SL, Gordeuk VR, Desai P, Shah N, Liles D, Trimnell C, Jonassaint CR. Badawy SM, et al. Among authors: liles d. JMIR Res Protoc. 2021 May 14;10(5):e29014. doi: 10.2196/29014. JMIR Res Protoc. 2021. PMID: 33988517 Free PMC article.
Race, rituximab, and relapse in TTP.
Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Liu A, Lim MY, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson A, Davis E, Evans MD, Mazepa MA; United States Thrombotic Microangiopathies Consortium. Chaturvedi S, et al. Among authors: liles dk. Blood. 2022 Sep 22;140(12):1335-1344. doi: 10.1182/blood.2022016640. Blood. 2022. PMID: 35797471 Free PMC article.
Vitamin D Deficiency in Adult Sickle Cell Patients.
Boettger PC, Knupp CL, Liles DK, Walker K. Boettger PC, et al. J Natl Med Assoc. 2017 Spring;109(1):36-43. doi: 10.1016/j.jnma.2016.10.003. Epub 2016 Nov 8. J Natl Med Assoc. 2017. PMID: 28259214
Sleep disorders in adult sickle cell patients.
Sharma S, Efird JT, Knupp C, Kadali R, Liles D, Shiue K, Boettger P, Quan SF. Sharma S, et al. Among authors: liles d. J Clin Sleep Med. 2015 Mar 15;11(3):219-23. doi: 10.5664/jcsm.4530. J Clin Sleep Med. 2015. PMID: 25515282 Free PMC article.
105 results